e-learning
resources
Stockholm 2007
Wednesday 19.09.2007
Biology in thoracic oncology
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Trail receptors as prognostic factors in non-small cell lung cancer
K. Leithner, E. Stacher, R. Wurm, F. Ploner, F. Quehenberger, J. Polachova, H. Samonigg, H. Popper, H. Olschewski (Graz, Austria)
Source:
Annual Congress 2007 - Biology in thoracic oncology
Session:
Biology in thoracic oncology
Session type:
Oral Presentation
Number:
4242
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
K. Leithner, E. Stacher, R. Wurm, F. Ploner, F. Quehenberger, J. Polachova, H. Samonigg, H. Popper, H. Olschewski (Graz, Austria). Trail receptors as prognostic factors in non-small cell lung cancer. Eur Respir J 2007; 30: Suppl. 51, 4242
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Surgical vs non-surgical treatment of early stage non-small cell lung cancer: here's the fight
N3 hilar sampling decision in the staging of mediastinal lung cancer
Related content which might interest you:
TNFα as a prognostic factor in surgically treated non-small cell lung carcinomas
Source: Annual Congress 2005 - Management of lung cancer: clinical problems
Year: 2005
Influence of histological subtypes of bronchioloalveolar carcinoma on prognosis and treatment
Source: Annual Congress 2006 - Prognostic factors in lung cancer
Year: 2006
Effects of prognostic factors on survival of the patients of non-small cell lung cancer
Source: Eur Respir J 2005; 26: Suppl. 49, 326s
Year: 2005
A novel biologic classification of non-small cell lung cancer
Source: Annual Congress 2005 - New insights into prognosis in thoracic surgical oncology
Year: 2005
Nuclear survivin in pN2 nonsmall cell lung cancer: prognostic and clinical implications
Source: Eur Respir J 2009; 33: 127-133
Year: 2009
Procalitonin: A prognosis factor in lung cancer and a marker for small-cell lung cancer
Source: Annual Congress 2011 - Instructive clinical aspects of lung cancer
Year: 2011
Age and stage at presentation in lung cancer
Source: Annual Congress 2005 - Management of lung cancer: clinical problems
Year: 2005
Effects of pretreatment prognostic factors and treatment on survival in advanced nonsmall cell lung cancer
Source: Eur Respir J 2003; 22: Suppl. 45, 431s
Year: 2003
Fascin-1 overexpression predicts a poor prognosis in non-small cell lung cancer
Source: International Congress 2017 – Lung cancer - clinical research: scientific pearls from the bedside
Year: 2017
Prognostic factors affecting survival in advanced non-small cell lung cancer patients
Source: Eur Respir J 2004; 24: Suppl. 48, 75s
Year: 2004
The impact of neuroendocrine differentiation in the prognosis of non-small cell lung cancer
Source: Annual Congress 2012 - Prognosis of lung cancer
Year: 2012
Interleukin-22 receptor is overexpressed in nonsmall cell lung cancer and portends a poor prognosis
Source: Eur Respir J 2016; 47: 1277-1280
Year: 2016
Staging of lung cancer
Source: Eur Respir Mon; 2009: 44: 150–168
Year: 2009
Predicting activity of EGFR (epidermal growth factor receptor) inhibitors in diffuse bronchiolo-alveolar carcinoma or so-called pneumonic adenocarcinoma
Source: Annual Congress 2006 - Bronchiolo-alveolar carcinoma
Year: 2006
Neuroendocrine differentiation as a prognostic factor in non-small cell lung cancer
Source: Eur Respir J 2007; 30: Suppl. 51, 669s
Year: 2007
Prognostic factors in non-small cell lung cancer
Source: European Multidisciplinary Conference in Thoracic Oncology 2009
Year: 2009
Risk factor for survival in never-smokers non-small cell lung cancer (NSCLC)
Source: Annual Congress 2010 - Thoracic malignancies: interesting case studies and series
Year: 2010
COX-2 as prognostic factor in lung cancer: systematic review of the literature with meta-analysis
Source: Annual Congress 2005 - Prognostic factors in lung cancer
Year: 2005
Lung cancer
Source: Respipedia Article
Year: 2018
Neuroendocrine differentiation is an independent prognostic factor in chemotherapy-treated non-small cell lung cancer
Source: Eur Respir J 2006; 28: Suppl. 50, 385s
Year: 2006
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept